Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma

Latest updates to the ESMO bone health guidelines

Exploring TKIs in metastatic sarcomas: Results of REGOBONE osteosarcoma cohort

Comparative effectiveness of lenalidomide, bortezomib, and their combinations for elderly myeloma patients

Synthesis, preclinical analysis, and first-inhuman phase I imaging of 89Zr-DFOdaratumumab for CD38 targeted imaging of myeloma

A phase 1b study of once-weekly KRd in patients with newly diagnosed multiple myeloma

D-VTd in transplant-eligible newly diagnosed MM: Subgroup analysis of high-risk patients in CASSIOPEIA

Real-world use of carfilzomib therapy among patients with existing cardiovascular medical history

Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma

Twice-weekly vs once-weekly Krd in early relapsed refractory multiple myeloma

HORIZON: Melflufen in high risk relapsed refractory multiple myeloma patients with extramedullary disease

Improved outcomes from quadruplet KCRD induction in newly diagnosed myeloma patients